These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1551764)

  • 1. [Regression of coronary arteriosclerosis by treatment of disorders of lipid metabolism? Initial clinical results and methodologic problems].
    von Essen R
    Internist (Berl); 1992 Jan; 33(1):62-6. PubMed ID: 1551764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of lipid lowering measures on coronary perfusion].
    Steinmetz A; Maisch B; Noll B
    Z Kardiol; 1997; 86 Suppl 1():43-55. PubMed ID: 9173721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic strategies for evaluating lipid metabolism disorders and therapeutic goals].
    Cremer P; Nagel D
    Internist (Berl); 1992 Jan; 33(1):32-7. PubMed ID: 1551761
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipids and lipoproteins in women.
    Sattler AM; Soufi M; Maisch B; Schaefer JR
    Herz; 2005 Aug; 30(5):368-74; quiz 429-30. PubMed ID: 16132239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
    Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
    Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European (EAS) and the American (NCEP) cholesterol guidelines: are they still adequate?
    Sztern M; Dujovne CA
    Postgrad Med J; 1989; 65 Suppl 1():S2-5. PubMed ID: 2622810
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of disorders of lipid metabolism--gastroenterologic aspects].
    Steinmetz A
    Z Arztl Fortbild (Jena); 1992 May; 86(9):437-44. PubMed ID: 1318619
    [No Abstract]   [Full Text] [Related]  

  • 8. Atherosclerotic lesions in humans--plaque stabilization and regression.
    Kritz H; Sinzinger H
    Wien Klin Wochenschr; 1995; 107(18):555-66. PubMed ID: 7483643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid lowering and coronary risk.
    Gotto AM
    Isr J Med Sci; 1996 Jun; 32(6):355-9. PubMed ID: 8682640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lipid regulation in the prevention of coronary heart disease.
    Bilheimer DW
    Eur Heart J; 1992 Jul; 13 Suppl B():23-8. PubMed ID: 1644098
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stable coronary artery disease -- diagnosis and therapy].
    Laufs U
    Dtsch Med Wochenschr; 2006 Mar; 131(11):556-62; quiz 563-4. PubMed ID: 16538560
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 16. [A 15-year follow-up of regression of atherosclerotic plaque of the coronary artery after partial ileal bypass].
    Sedletskiĭ IuI; Lebedev LV; Mirchuk KK; Azovtsev RA
    Vestn Khir Im I I Grek; 1999; 158(5):72-3. PubMed ID: 10645591
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid metabolism disorders--diagnosis and therapy in general practice. 8: Mixed hyperlipoproteinemias].
    Richter WO
    Fortschr Med; 1996 Jul; 114(18-19):248-50. PubMed ID: 8766794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Need for treatment and treatment possibilities of hypercholesterolemia].
    Seidel D; Cremer P
    Verh Dtsch Ges Inn Med; 1990; 96():168-75. PubMed ID: 2092436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
    Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.